"However, it didn't explain how previous prohibitionbased policies designed to reduce cannabis use have driven up the strength of street cannabis, the source of most cannabis for people with psychosis, thus making the problem worse."
"Furthermore, growing data from the Drug Science T21 project and other prescription databases globally shows that medical cannabis can alleviate a range of psychiatric and neurological disorders, without inducing psychosis."
"Any suggestion that rates of cannabis-related psychosis could be reduced by limiting medical cannabis access is flawed and is likely to harm patients currently benefiting from it."
Prohibition-based policies intended to reduce cannabis use have incentivized a shift toward higher-strength street cannabis, increasing exposure to high-THC products among vulnerable people and elevating psychosis risk. Street cannabis remains the primary source for many people who develop cannabis-related psychosis, and potency escalation worsens outcomes for that group. Concurrently, growing prescription and research data, including the Drug Science T21 project, indicate that medical cannabis can alleviate various psychiatric and neurological disorders without inducing psychosis in treated patients. Restricting medical cannabis access on the basis of psychosis concerns risks harming patients who currently derive therapeutic benefit.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]